ReviewDiabetologia2025
Variation in type 2 diabetes prevalence across different populations: the key drivers.
Review in Diabetologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Association of glycemic control and chronic kidney disease with hospitalization in type 2 diabetes in a cross-sectional study in Region Halland.Scandinavian journal of primary health care · 2026Review
- Association Between Diabetes Prevalence and Mortality from Gastrointestinal Cancers in Türkiye: A Longitudinal Ecological Study.Journal of clinical medicine · 2026Article
- Associations between frailty dimensions and quality of life in older adults with Type 2 diabetes Mellitus: A cross-sectional study.Aging clinical and experimental research · 2026Article
- Diabetes knowledge and attitudes among non-diabetic adults in Iraq: A cross-sectional study of awareness, risk perception, and preventive understanding.The Journal of international medical research · 2026Article
- From Beat to Risk: How Heart Rate Variability Predicts Arrhythmias in Type 2 Diabetes.Life (Basel, Switzerland) · 2026Review
- Equity, Diversity and Inclusion is essential for rigorous science and good for health.Diabetologia · 2026Article
- Navigating ambivalence: perspectives on healthy eating habits and readiness for change among Swedish men with prediabetes.Frontiers in clinical diabetes and healthcare · 2026Article
- Macrovascular complications in type 2 diabetes: a multiregional study in rural Bangladesh.Frontiers in endocrinology · 2026Article
- Association Between Body Composition and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
- Three-dimensional-printed ROS-scavenging and immunomodulatory hydrogel accelerates diabetic wound healing through synergistic microenvironment regulation.Regenerative biomaterials · 2026Article
- The Gut Microbiota-Metabolic Axis: Emerging Insights from Human and Experimental Studies on Type 2 Diabetes Mellitus-A Narrative Review.Medicina (Kaunas, Lithuania) · 2025Review
- Diabetes prevention and treatment: a global perspective.Diabetologia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global prevalence of type 2 diabetes has risen sharply in recent decades, with significant regional and demographic variation. While high- and middle-income countries generally report a higher diabetes prevalence than low-income countries, substantial differences exist within these categories. The highest prevalence is observed in regions such as the Middle East and North Africa, whereas parts of Europe and sub-Saharan Africa report a much lower prevalence. Several factors drive these disparities, including urbanisation and industrialisation, which have led to changing lifestyles, including more sedentary behaviours and greater consumption of processed, energy-dense foods, particularly in rapidly developing economies. The rising prevalence of obesity, driven by these lifestyle changes, further exacerbates health disparities, significantly increasing the risk of developing type 2 diabetes. Declining mortality rates among people with diabetes, and incidence, will also impact prevalence. Genetic predisposition influences diabetes risk, with certain populations, such as Indigenous and Pacific Islander groups, exhibiting higher susceptibility. Environmental factors, including air pollution and persistent organic pollutants, also impact diabetes prevalence, and disproportionately affect lower income regions. Migration plays a role at both individual and population levels, with migrant populations from high-risk regions often having a higher diabetes prevalence than host populations due to lifestyle and socioeconomic changes they experience. Additionally, healthcare access and diagnostic practices vary widely, leading to underdiagnosis of type 2 diabetes, particularly in low-resource settings. Addressing these disparities requires a comprehensive approach that considers socioeconomic factors, environmental factors and weight management to develop effective prevention and intervention strategies worldwide.
Indexed as
Identifiers
40760250What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.